JPRN-UMIN000040194已完成未知
Durvalmab plus platinum-etoposide versus atezolizumab plus platinum-etoposide in extensive- stage small cell lung cancer: a systematic review. - Durvalmab plus platinum-etoposide versus atezolizumab plus platinum-etoposide in extensive- stage small cell lung cancer
Showa University School of Medicine0 个研究点目标入组 940 人开始时间: 2020年4月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 940
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Case report Observational studies non-randomized controlled trials
研究者
相似试验
进行中（未招募）
1 期
EOADUVANT ATEZOLIZUMAB AND ADJUVANT ATEZOLIZUMAB + BEVACIZUMAB IN COMBINATION WITH PERCUTANEOUS RADIOFREQUENCY ABLATION OF SMALL HCCDigestive oncologyEUCTR2020-000569-18-FRniversity Hospital of Montpellier202
进行中（未招募）
1 期
etrozole versus Letrozole plus lapatinib (GW572016) in hormone-sensitive, HER-2 negative operable breast cancer. A double blind randomized phase II study with biomarker evaluation - LETLOBEUCTR2006-001907-13-GBGlaxoSmithKline Research and Development Limited
招募中
2 期
EFFICACY OF ATEZOLIZUMAB CONCURRENT WITH RADIOTHERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER2024-514604-14-00Grupo Espanol De Oncologia Genitourinaria-Socug39
进行中（未招募）
1 期
EFFICACY OF ATEZOLIZUMAB CONCURRENT WITH RADIOTHERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCERMuscle-invasive bladder cancerCTIS2024-514604-14-00Grupo Espanol De Oncologia Genitourinaria-Socug39
进行中（未招募）
2 期
OGIK2001(SPEED)extensive disease small Cell Lung Cancer(ED-SCLC)SCLC, Extensive-Stage, brain metastasisD055752JPRN-jRCTs071210036Okamoto Isamu41